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Abstract
Genetically diverse RNA viruses like dengue viruses (DENVs) segregate into multiple, genetically distinct, lineages that
temporally arise and disappear on a regular basis. Lineage turnover may occur through multiple processes such as,
stochastic or due to variations in fitness. To determine the variation of fitness, we measured the distribution of fitness within
DENV populations and correlated it with lineage extinction and replacement. The fitness of most members within a
population proved lower than the aggregate fitness of populations from which they were drawn, but lineage replacement
events were not associated with changes in the distribution of fitness. These data provide insights into variations in fitness
of DENV populations, extending our understanding of the complexity between members of individual populations.
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Introduction
Dengue viruses (DENVs) are the world’s most important
mosquito-borne viral pathogens for humans in terms of morbidity,
mortality and economic impact. DENVs consist of four antigen-
ically distinct serotypes (DENV 1–4), which cause a wide spectrum
of clinical manifestations. An estimated 3.6 billion people in the
global population and approximately 120 million travellers are at
risk of DENV infection. The number of dengue cases reported
annually is 50–100 million, with approximately 24,000 deaths in
children [1–4]. There is no commercially available DENV vaccine
or DENV specific antiviral therapies, despite more than fifty years
of research in this field [5].
DENV is a single stranded, positive sense RNA virus belonging
to the genus Flavivirus (family Flaviviridae). Due to the error
prone nature of the RNA-dependent RNA polymerase (RdRP)
and genome recombination [6–8], DENVs raise significant genetic
diversity during their replication [9]. Phylogenetic studies of
DENV serotypes showed that they form diverse phylogenetic
clusters, that consist of multiple distinct lineages [10,11]. The
lineage extinction and replacement on a regular basis is the most
surprising feature of DENVs evolutionary dynamics [10]. A
lineage that persists for a number of years at a given geographical
location sometimes becomes extinct, as an entirely new lineage
takes over [12]. Lineage replacement events on a regional scale are
well documented. For example, DENV-1 lineage replacements
were observed in Myanmar, Cambodia, Thailand in the late 1990s
[13], in the mid-1990s [12,14] and in the early 2000s [15]
respectively. Similarly, DENV-2 lineage replacements were
observed in Vietnam in the early 2000s [16]. DENV-3 lineage
replacements were observed in Sri Lanka in the late 1980s [17],
and in Thailand in the early 1990s [18]. And DENV-4 lineage
replacements were observed in Puerto Rico during the 1980s and
1990s [19]. A more global lineage replacement event has also been
reported [20], in which DENV-2 lineages from Southeast Asia
displaced the American DENV-2 lineage in the Americas during
the early 1990s.
Exploring the causes of DENV lineage replacement has
important implications for dengue epidemiology and control
[14,17,20–23]. As DENV antigenic properties often differ between
lineages, understanding the mechanisms that underlie lineage
turnover will influence vaccine design [14,24], and the putative
mechanisms of lineage replacement are used to develop prediction
models for future dengue epidemics [14,16]. Despite this potential
significance, there are multiple explanations exists on whether
lineage replacement events result from the random sampling of
viral variants during genetic bottlenecks due to the stochastic
nature of DENV transmission, or from variations in fitness within
discrete viral populations. For the purposes of this work, fitness is
defined as the ability of DENV-1 virions to replicate in cultured
cells.
Some phylogenetic studies have suggested that observed DENV
lineage replacement events were due to either a higher viraemia in
the human host [16] or enhanced infectivity in mosquito vectors
[14,25–27], while others suggested that the data were more
consistent with stochastic events [13,18]. With respect to viral
fitness in other systems, fewer than 5% of members of Vesicular
stomatitis virus (VSV) populations were reported to be more fit
than the population from which they were drawn [28], and
mixtures of Ross river virus (RRV) populations containing less
than 1% of a virulent strain nonetheless displayed a virulent
phenotype [29]. Despite these observations, the distribution of
fitness in DENV populations has been not yet been quantified and
correlated with epidemiological patterns, like lineage extinction
and replacement during transmission. Here, we measured
distribution of fitness within DENV populations with differing
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epidemiological histories and correlated them with observed
lineage extinction and replacement events.
Materials and Methods
Ethics statement
This study was approved by the Queensland University of
Technology Research Ethics Unit (Ethics No. 0700000910). As no
patient tissue was employed in this study, the University Ethics
Unit did not require informed patient consent. All patient
identifiers were removed from dengue virus samples before they
were used for research purposes.
Study population
Viruses were recovered from acute phase sera from dengue
patients admitted to the Yangon Children’s Hospital [30]. Strains
of DENV used in the study, which are described in Table 1, were
passaged once in C6/36 before sequencing.
Cell lines and virus isolation
Cell lines were maintained in RPMI-1640 medium (Invitrogen)
supplemented with 10% (v/v) heat-inactivated fetal bovine serum
(FBS) (Invitrogen) and 1% (v/v) L-Glutamine (200 mM) Penicillin
(10,000 units) Streptomycin (10 mg/ml) (Sigma). C6/36 cells were
incubated at 30uC and all others were at 37uC in an atmosphere of
5% CO2/air. Viruses were isolated in C6/36 cells from serum
samples collected from Myanmar by using a previously published
protocol [31].
Cell culture ELISA
Monolayers of cells in 96-well plates (Nunc) were infected with
200 ml tenfold dilution of DENV and incubated for 8 days.
Culture supernatant from each culture was removed and cell
monolayers were fixed with 5% (v/v) formaldehyde in PBS for
30 minutes at room temperature. After four washes with PBS-T,
100 ml 0.5% (v/v) triton X-100 in PBS was added to the
monolayers for 5 minutes at room temperature. After a further
three washes with PBS-T, the cells were blocked with 2% (w/v)
skim milk in PBS for 30 minutes at room temperature. HRP
labelled 6B6C-1 antibody [32] was diluted 1:3000 with 2% (w/v)
skim milk in PBS and 100 ml were added to each well and
incubated for 1 hour at room temperature. Cells then were washed
six times with PBS-T and 50 ml TMB solution was added. Virus
infected cells were stained blue.
Immunofluorescence assays
Confluent adherent (C6/36, BHK-21 clone 15, HuH-7 and
HS1) and non-adherent (K562 and U937) cells in 12 well plates
were infected with 200 ml DENV (DENV-1, -2, -3, -4) in serum-
free RPMI-1640. After 1 hour of infection, 1 ml RPMI-1640
containing 2% v/v FBS was added to each well and incubated for
12 days. Supernatant from each culture was removed after 12
days. 5 ml of cell suspensions from each dilution were added to
each well of a 12 well, teflon coated, immunofluorescence slides
(ICN Biomedicals). Excess liquid was aspirated from the spots and
cells were air dried for 15 minutes at room temperature before
being fixed in ice cold acetone for 4 minutes. 50 ml of a anti-
DENV monoclonal antibody solution (M10 for anti- DENV-1,
3H5 for anti-DENV-2, 5D4 for anti-DENV-3 and 1H10 for anti-
DENV-4) [33] were added to each spot and incubated for one
hour at room temperature. The slides then were washed three
times with PBS, each for 10 minutes. 50 ml of a secondary
antibody solution composed of a 1:30 dilution of fluorescein
isothiocyanate (FITC) labeled anti-mouse IgG (Dako) and a 1:80
dilution of FITC labeled rabbit anti-human IgM (Dako) in PBS
was added to each spot and incubated for 45 minutes at room
temperature. The slides were washed with PBS three times again
each for 10 minutes. Cover slips were mounted on the slides and
the cells examined under a fluorescent microscope (Eclipse, Nikon)
using ploem illumination. The images were recorded using
photometric CoolSnap (Nikon). Cells were considered infected if
a clear green fluorescence was observed in the cytoplasm of the
Table 1. Strains of DENV-1 used.
Serotype Strain Country
Date of
Isolation
Accession
number Source
Passage
number
DENV-1 31459 Myanmar 1998 AY588272 [67] P1 in C6/36
31987 Myanmar 1998 AY588273 [67] P1 in C6/36
32514 Myanmar 1998 AY600860 [67] P1 in C6/36
36957 Myanmar 2000 AY620951 [67] P1 in C6/36
43826 Myanmar 2001 DQ264966 [34] P1 in C6/36
44988 Myanmar 2002 AY726552 Unpublished P1 in C6/36
47317 Myanmar 2002 KF559253 This study P1 in C6/36
47662 Myanmar 2002 DQ265041 [34] P1 in C6/36
49440 Myanmar 2002 DQ265137 [34] P1 in C6/36
62690 Myanmar 2005 KF559255 This study P1 in C6/36
68417 Myanmar 2007 KF559256 This study P1 in C6/36
80579 Myanmar 2009 KF559257 This study P1 in C6/36
Infectious clone Myanmar 2002 KF559254 This study 1 X BHK, 1 X C6/36
DENV-2 New Guinea C New Guinea 1944 AF038403 [68] Multiple, unknown
DENV-3 H87 Philippines 1956 M93130 [69] Multiple, unknown
DENV-4 H241 Philippines 1956 AY947539 Novartis Institute for
Tropical Diseases
Multiple, unknown
doi:10.1371/journal.pone.0107264.t001
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infected cells. Fluorescent and transmitted light images were
recorded for each field.
Indirect ELISA
50 ml of supernatant from DENV infected, or uninfected cell
cultures were diluted with an equal volume of chilled borate saline
(B.S) pH 9.0 (B.S) and added to 96 well ELISA plates (Maxisorb,
Nunc) at 4uC for 24 hours. The plates then were washed five times
with PBS-T and 100 ml of HRP-labeled 6B6C-1 diluted in 1:6000
in PBS-T was added to each well and incubated for 45 minutes at
room temperature. The plates then were washed six times with
PBS-T and 100 ml soluble TMB (ELISA Systems) was added to
each well and incubated for 20 minutes for colour to develop.
50 ml of 1 M sulphuric acid (H2SO4) was added to each well to
stop the reaction. The absorbance in each well was determined
with an ELISA plate reader (Beckman Instruments) at a
wavelength of 450 nm against a blank of 620 nm.
Assay for distribution of fitness
DENVs were diluted two-fold (1 in 2 to 1 in 128) to provide a
theoretical ‘‘one infectious unit’’ of virus as an input to individual
cell cultures in 96-well plates i.e. ,66 of the 96 well C6/36 cells
monolayer’s were infected. Two wells in each 96-well plate (A1
and B1) were infected with undiluted DENV as control (Fig. S1).
Yield of prototypes strains of DENV, in cultures of A. albopictus
(C6/36) cells, infected with ten-fold dilutions was peak at about 8
days irrespective of MOI (Figure S2). Eight days after infection,
the culture supernatant from each of the 96-wells was transferred
into corresponding wells in a second 96-well plate. The amount of
virus released from cells in each culture was determined by
indirect ELISA in the second plate described previously (Fig. S1).
We calculated mean and +/22 standard deviations of the control
values to determined 95 confidence interval of the range for
statistically valid comparison with the fitness of individual
populations. Cell monolayers in the original plate were stained
for DENV E protein by cell ELISA as described previously.
RNA extraction and RT-PCR and sequencing
RNA was extracted from 140 ml samples of virus using the
QIAamp Viral RNA mini kit (Qiagen), according to the
manufacturer’s instructions. RNA was quantified by spectropho-
tometry. Equal amounts of RNA were used for RT. Complemen-
tary DNA (cDNA) was produced from the RNA of DENV using
random hexanucleotide primers (Boehringer Mannheim) and
expand reverse transcriptase (Expand RT; Roche). Briefly, 1 ml
random hexamer primers (200 ng/ml) was added to 11 ml RNA in
a 0.5 ml tube (LabAdvantage) and the mixture was incubated at
65uC for 5 minutes in a heating block before being placed on ice
for 2 minutes. Four microliters of 5x RT buffer (Roche), 1 ml
100 mM DTT (Roche), 1 ml 10 mM dNTPs (Roche), 1 ml RNAse
inhibitor (40 unit/ml; Roche) and 1 ml expand RT (50 unit/ml)
were added to the tube and the volume made up to 20 ml with
nuclease free water. RT reactions were incubated at 55uC for 1.5
hours. The primers used for PCR amplification corresponded to a
region of the E of DENV-1, which were: D1 843F, 59-
ATGCCATAGGAACATCC 39 and D1 2465R, 59-TTGGTGA-
CAAAAATGCC 39. Five microliters of 10x Expand high fidelity
PCR buffer with 15 mM MgCl2 (Roche), 1 ml 10 mM dNTP, 2 ml
forward primer (100 ng/ml), 2 ml reverse primer (100 ng/ml),
0.75 ml Expand high fidelity PCR system (3.5 unit/ml; Roche), 5 ml
cDNA and 34.25 ml nuclease free water were mixed to make the
total volume of 50 ml. PCR was performed using cycling
conditions of 94uC for 2 minutes for one cycle and then 92uC
for 30 seconds, 58uC for 40 seconds and 68uC for 2.30 minutes
for 10 cycles, 92uC for 30 seconds, 58uC for 30 seconds and 68uC
for 3 minutes for 10 cycles, 92uC for 30 seconds, 58uC for
30 seconds and 68uC for 3.30 minutes for 18 cycles run for 39
cycles followed by 68uC for 10 minutes for final extension. PCR
products were electrophoresed on 1.0% agarose in 1x TBE buffer
and products of the correct size were gel purified with the
MinElute PCR purification kit (Qiagen), according to the
manufacturer’s instructions. The purified DNA (100 ng per
300 bp of product) was added to 3.2 pmol of oligonucleotide
primers (forward and reverse) in a final volume of 12 mL. The
remaining sequencing reaction was performed by Australian
Genome Research Facility Ltd (AGRF), Brisbane. Sequencing
was performed on automated ABI 3730 DNA Analyzer (Applied
Biosystems) using dye-terminator chemistry.
Sequence Alignments and Phylogenetic Analysis
Alignment of the consensus sequences were performed using the
ClustalW program in the Geneious Pro 6.1. The aligned nucleic
acid sequences were used to construct bootstrapping phylogenetic
tree using the Neighbor-joing tree building method and Tamura-
Nei genetic distance model in the Geneious Pro 6.1.
Results
Phylogenetic relationship between DENV-1 isolates
Analyses of Myanmar DENV-1 E gene sequences from
Genbank and unpublished sequences (Table 1) produced a
phylogenetic tree with five distinct branches (Fig. 1). Lineage A
contained the first DENV-1 isolate recovered in Myanmar
(Burma, Bur76 and Mya76). This lineage became extinct in
1998, about the same time lineages B and C appeared. No
examples of lineage B have been recovered since 2002, but lineage
C was still circulating in 2008. Lineage D was first detected in
2006, and was still circulating in 2008. The single example of
lineage E, which was most closely related to DENV-1 from
Vietnam, did not appear to have established cycles of transmission
and was excluded from analysis. For the purposes of analysis,
lineages A and B are considered to have become extinct in 1998
and 2002, respectively. Lineages C and D were deemed to be still
circulating in 2008. The strains in bold type in Figure 1 were
regarded as representative of their lineage and were used in
subsequent studies.
Susceptibility of vertebrate and invertebrate cell lines to
infection with DENV
Because subsequent fitness studies required that DENV be
cultured in both mosquito and relevant human cell lines, the
susceptibility of C6/36 (mosquito) cells and a range of human cell
lines (HuH7, HepG2, HC04, K562, U937, HS1 and SW987) to
DENV infection was determined. Baby Hamster kidney (BHK-21)
cells were included as a control substrate. With the exception of
HuH7 cells, the human cell lines were uniformly refractory to
infection with prototype strains of DENV (Table S1). Subsequent
experiments with low passage DENV isolates and other DENV
populations of interest were performed only in C6/36 and HuH7
cells (Table 2). As subsequent experiments required serum-free cell
culture, the yield of DENV isolated from C6/36 cells cultured with
and without a FBS supplement was assayed (Table 2) and showed
no significant difference (p.0.05, student t-test). As previously
observed (Table S1), the yield of DENV from HuH7 cells was
consistently lower than that from C6/36 cells. C6/36 mosquito
cells were as much as one million times more sensitive to infection
with low passage strains of DENV-1. No DENV production was
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detectable in HuH7 cells infected with 8 of the 20 DENV strains
studied.
Distribution of fitness within population of DENV-1
Stocks of viruses from the three lineages in Fig. 1 (A, B, C) were
limit diluted to provide a theoretical ‘‘one infectious unit’’/200 ml
inoculum (i.e. 65 of the 96 wells contained infectious virus) and
used to infect monolayers of C6/36 cells in 96 well plates. Eight
days after infection, at the time of peak virus production (Fig. S2),
the amount of virus released from C6/36 cells in each well was
determined by indirect ELISA (Fig. S1). The amount of virus from
cultures infected with one infectious dose of virus was compared
with that of the population from which it was derived i.e. cell
monolayers in the 96 well plate infected with corresponding
undiluted stock virus. The mean absorbance (62 s.d.) was
calculated for the duplicate control wells containing undiluted
stock of the DENV-1 population being analysed (A1, B1; Fig. S1).
Supernatants from cultures giving rise to an ELISA absorbance
similar to the mean (62 s.d.) for cultures A1, B1 (undiluted stocks
of virus) were regarded as having the same fitness is the population
from which they were derived. Supernatants from cultures giving
rise to an ELISA absorbance of more than 2 s.d. less than the
mean for cultures A1 and B1 were regarded as less fit.
Supernatants from cultures giving rise to an ELISA absorbance
of more than 2 s.d. greater than the mean for A1 and B1 were
regarded as more fit. The numerical fitness distribution within
each of these classifications (more, average, less fit) is presented in
Table S3. The distribution of fitness within populations of DENV-
1 (lineages A, B and C) is shown in Fig. 2.
Less than 2 per cent (fewer than 1 in 94) of the members of
DENV-1 populations collected in 1998 (lineages A, B, C) were
more fit than the population from which they were drawn (p,
0.05, Chi-Square-test) (Fig. 2).
Members of all populations recovered after 1998 contained
some members (14.1% to 45.71%) that were more fit than the
population from which they were derived except for the sample
Figure 1. Phylogenetic analysis of the E gene of DENV-1 showing lineage extinction and replacement of DENV-1 in Myanmar.
Bootstrap values (100 replications) for key nodes are shown. A distance bar is shown below the tree. Lineage A, B and E are extinct and lineage C and
D are still circulating. Strains selected for study have been highlighted.
doi:10.1371/journal.pone.0107264.g001
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recovered in 2000 (36957/00, lineage B) which showed an
increase in the prevalence of more fit members. Most of the post-
1998 samples were recovered after the explosive outbreak of
DENV-1 infection in Myanmar in 2001 and showed an increase in
the prevalence of more fit members. While DENV populations of
both lineages B and C appeared to be gaining (14.1% to 45.71%)
more fit members, only lineage C has survived.
Fitness distribution in lineage B and C represents a polarization
of fitness which increased in both numbers (more and less fit). We
observed that 75% of the viral strains were polarized in extinct
lineage B, whereas only 20% of the viral strains were polarized in
circulating lineage C, (P= 0.09, Pearson Chi-square statistics = 2)
(Table 3). We considered the fitness was being polarized when
more than 33% (one third) populations were more and less fit than
average fitness. We excluded linage A from this analysis because of
limited number of samples for statistically valid comparison.
Discussion
DENV lineage turnover is commonly observed in DENV
evolution, but it is unclear whether lineage replacement events are
caused by selective pressure or by random sampling during
transmission. While DENV populations are highly diverse [18,34–
39], the overall fitness of a DENV population in an individual host
is unlikely to be simply the sum of individual fitness. Other
similarly diverse arboviruses exhibit characteristics consistent with
synergy within their viral populations. For example, less than 5 per
cent of VSV virions within a population were more fit than the
population from which they were drawn [28], and RRV
populations containing less than 1% of a virulent strain
nevertheless displayed a virulent phenotype [29]. Recent obser-
vations that defective DENV genomes can be complemented by
fully competent genomes to overcome the defect [31] supports the
concept of cooperativity within DENV populations. To date, there
has been no attempt to quantify the distribution of fitness within
DENV populations, and to correlate these data with epidemio-
logical patterns. Here we report the distribution of fitness within
populations of DENVs collected from Myanmar between 1998
and 2005.
Our observation that all members of DENV-1 populations
collected in 1998 were less fit than the overall fitness of the
populations from which they were drawn regardless of lineage
(Fig. 2) is consistent with extensive complementation among the
90–99% of DENV genomes that are incapable of self-replication
[16,40,41]. The distribution of fitness appeared to polarise in
subsequent years, in which the fraction of the population that was
more fit than the overall population fitness increased. This was
especially apparent for lineage B from 1998 to 2002 (Fig. 2). The
proportion of individuals in DENV-1 populations that were more
fit than the population as a whole increased after the explosive
outbreak of DENV-1 infection in 1998, suggesting that more fit
viruses may have been selected during the rapid transmission
accompanying the outbreak. However, an increase in the
proportion of ‘‘more fit’’ members of a DENV population did
not guarantee survival of a lineage, as lineage B became extinct
between 2002 and 2005.
We observed a trend (although statistically not significant,
P= 0.09, Pearson Chi-square statistics = 2) that fitness of extinct
Table 2. Infectivity of dengue viruses (DENVs) for mosquito (C6/36) and human (HuH7) cell lines.
Dengue virus Titre of virus (log10TCID/ml)
Serotype Strain C6/36 without FBS C6/36 with FBS HuH7 without FBS HuH7 with FBS
DENV-1 Hawaii 6.5 5.5 ,1.0 ,1.0
31459 7.0 6.5 ,1.0 2.0
31987 5.5 5.0 ,1.0 3.0
32514 7.0 6.5 3.0 3.0
62699 6.0 4.5 ,1.0 ,1.0
63001 5.5 5.0 ,1.0 2.0
75971 5.5 5.5 ,1.0 2.0
84077 8.0 7.5 3.0 3.0
84558 7.5 7.0 ,1.0 2.0
I. C 7.5 7.0 ,1.0 4.0
DENV-2 New Guinea C 8.0 8.0 4.0 4.0
I. C 8.0 8.0 4.0 4.0
DENV-3 H87 7.5 7.5 ,1.0 2.0
82899 7.0 5.5 ,1.0 ,1.0
83468 5.0 4.5 ,1.0 ,1.0
84014 7.0 6.5 ,1.0 ,1.0
84700 4.5 3.5 ,1.0 ,1.0
DENV-4 H241 7.0 7.0 ,1.0 2.0
84711 6.5 5.5 ,1.0 ,1.0
84087 7.0 6.5 ,1.0 ,1.0
DENVs isolated from clinical patients in C6/36 were infected in C6/36 and Huh7 with ten-fold dilutions to determine the relative titres in both cell types. Both cells (C6/
36 and Huh7) were infected at the same time with the same dilution of DENVs to determine the relative titres.
I.C. Infectious clone derived DENV-2.
doi:10.1371/journal.pone.0107264.t002
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lineage was more polarised (.50%) than circulating lineage. It is
possible that polarisation of fitness within a lineage population in
which the ‘‘more fit’’ viruses specialising in high virus titre support
the ‘‘less fit’’ viruses within the same population. If true, the less fit
viruses presumably specialise in some other characteristics which
are important for lineage survival (i.e. increased replication rate or
increased ability to evade the host immune system), and similarly
support more fit viruses within their lineage population. Such
specialisation represents a loss of fitness homogeneity that could
result in populations that are more vulnerable to stochastic
sampling (bottleneck) effects. For example, the distribution of
fitness of a small-sized random sample from a homogeneous 1998
lineage population would likely represent of the overall population
with respect to fitness distribution, and thus would likely maintain
the cooperative characteristics of the population from which it was
drawn. However, the fitness distribution of a similarly small-sized
random sample from the polarised 2002 lineage population would
be less likely to accurately represent the fitness distribution of the
source population. If the random sample were to contain
insufficient numbers of more fit viruses to effectively support the
less fit viruses, the lineage would become vulnerable to extinction.
However, more data would be required to verify this interpreta-
tion as this is not statistically significant (P= 0.09, Pearson Chi-
square statistics = 2) (Table 3). The results could be statistically
significant if we had sufficient number of samples. Unfortunately,
in this study our sample numbers are not high. Further studies
required with large number of samples to determine whether
Figure 2. Distribution of fitness within populations of DENV-1 from four lineages. Populations are identified as strain/year/E (extinct) or C
(circulating); proportion more fit than the population average indicated horizontal hatch, same fit as the original population indicated as bold squares
and less fit than the original population indicated as small squares.
doi:10.1371/journal.pone.0107264.g002
Table 3. Relationship between DENV lineage extinction and polarization in fitness in populations.
DENV fitness polarization Lineage Total
Extinct Circulating
Polarized 3 1 4
Non-polarized 1 4 5
Total 4 5 9
75% of the extinct viral strains were polarized and 80% of the circulating strains were non-polarized. We have conducted a Chi-square test of independence to test the
null hypothesis that there is no association between polarization and virus extinction. The test results show that there is no statistically significant association between
polarization and virus extinction (Pearson Chi- square statistic = 2.7, p=0.09).
doi:10.1371/journal.pone.0107264.t003
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fitness polarisation in DENV population has any impact on
lineage extinction.
We observed no association between the distribution of fitness of
members with DENV-1 populations in mosquito cells and the
survival or extinction of a lineage of viruses (Fig. 2). However,
there was an increase in the proportion of more fit members
during and after the 2001–2002 outbreaks, suggesting that there
may have been some selection for DENV that grew to high titre in
mosquitoes. This observation has two caveats. The first is that
there was an increase in the proportion of more fit members in
population 36957/00, compared to 31459/98 (clade B) before the
outbreak began (36957/00 was recovered in the dengue season of
2000 in which the number of reported cases was low). The second
is that the half life of an Aedes aegypti mosquito in Thailand (and
presumably in neighbouring Myanmar) is only 7–8 days [42] and
so selection might be for a virus that replicated faster rather than
one that grew to high titre. However, DENV, which grows to high
titre, may also reach significant titres earlier.
Fitness can be defined as a measure of the ability to replicate
(and produce infectious progeny) in a host [43,44] but a more
appropriate definition could be a measure of the ability to be
transmitted, i.e. to infect the next host in a transmission cycle.
While transmissibility is probably the most relevant measure for a
virus like DENV, with infection cycles involving alternate human
and mosquito hosts, technical constraints prevented this measure
being used. In this study, fitness was defined as the yield of DENV-
1 virions from infected cells.
An indirect ELISA procedure was employed to estimate the
quantity of DENV virions released into a culture supernatant (see
Materials and Methods). It was accepted that a proportion of these
would contain genomes that were not infectious. However, given
the complexity of the interactions between RNA genomes e.g.
complementation, interference by sub-genomic RNA etc., the
yield of virions was a more relevant measure of productive
infection than estimates of either the number of infectious virus
particles (able to infect cell substrate) or of genome copy number.
A comparison of titres of DENV in patients measured as
infectious virus or as genome copy number suggested that copy
number values are 10–100 times higher than infectious titres
[16,40,41]. That the individual members of DENV populations
might vary in their fitness is not surprising given that there are
reports of virions with genomes with mutations and indels giving
rise to intragenic stop codons as well as genomes with deletions of
thousands of nucleotides [31,34,37,45–49] There also is an
extensive literature describing non-lethal changes that effect
DENV replication [50–53]. Taken together with the comments
above, it is unlikely that an individual cell is infected by a single
DENV genome. For these reasons, a unit, ‘‘one infectious dose’’
has been used in this study and has been derived statistically, i.e. if
96 infectious units of virus in 9.6 ml are aliquoted uniformly into
96 wells of a microtitre plate, only 65 wells will contain virus (some
wells will contain more than one infectious dose). While this is a
weakness of this approach, there was no alternative, and the same
methodology was used for all populations, so enabling compar-
isons to be made.
It was important to select appropriate human and mosquito cell
lines for a suitable surrogate to measure fitness in vitro. The
primary and/or major sites of DENV replication in humans are
not known yet. Therefore, it was unclear what cells or cell lines
might be appropriate substrates for experiments relevant to the
human condition. A survey of the literature (Table S2) suggested
DENV could be identified most commonly in the liver, as it was
associated with liver dysfunction [54–56] and pathology [55,57–
59] but it was not clear whether this was due to the extensive
phogocytic activity of the liver [60–65] or that cells in the liver are
more susceptible to infection than those in other tissues. However,
in this study, all human cell lines including a number of liver cell
lines, were extremely refractory to infection by the low passage
DENV-1 (Table 2). The use of HuH7 cells in this study reflected
that these cells appeared to be the best available rather than that
they were a productive cell substrate. Other investigators [66] have
struggled to find human cell lines that are uniformly susceptible to
infection by DENV from patient serum or by low passage DENV
isolates.
These investigations focussed on DENV infections in C6/36
mosquito cells. Mosquito cell is not a perfect representation to
measure fitness; however, it is representation of mosquito vectors.
Additional information may have been revealed if similar studies
were undertaken in human cells, and more informative changes
may have been revealed if similar studies were undertaken in
human cells. However, it was not possible to identify a human cell
line that was sufficiently susceptible to infection with all low
passage strains of DENV (Table 2). Furthermore, the most
susceptible human cell line, HuH7, required a FBS supplement
for growth and the FBS reduced the sensitivity of the ELISA
method employed to quantitate DENV in culture supernatants.
This study has provided clear evidence that the lineage turnover
in DENV transmission is not due to any selective pressures
because of the variation in fitness within populations. While we
observed a trend that fitness of extinct lineage DENV populations
was more polarised than circulating lineage, impact of polarisation
of fitness in population in DENV lineage extinction need to be
further explored. As Myanmar is a hyperendemic country, the
presence of multiple DENV serotypes may result in complex
patterns of cross-immunity, which might determine which clades
survive and which become extinct [13,30]. The explanation for
clade replacement may lie with the phenotype of the host with the
more susceptible hosts (host proteins able to support the
replication of DENV most efficiently; the innate immune system
least able to resist infection) being infected more readily after
appearance of a new clade such that, after several years, the virus
struggles to survive. A new clade, with a different phenotype, may
be able to exploit hosts which the resident clade is struggling to
infect.
Supporting Information
Figure S1 Distribution of fitness within populations of
DENV-1. Serial dilutions of DENV were added to 94 wells of 96
well plates containing monolayers of C6/36 cells. Undiluted virus
was added to the two remaining wells shown within bracket. Eight
days later the supernatants from the cultures were transferred to
96 well ELISA plates and the cell monolayers stained for DENV
antigen by indirect ELISA. The amount of DENV in each
supernatant was quantified by indirect ELISA.
(TIF)
Figure S2 Yield of prototypes strains of DENV in
cultures of A. albopictus (C6/36) cells infected with
ten-fold dilutions of (a) DENV-1, (b) DENV-2, (c) DENV-3
and (d) DENV-4 (X 1021,& 1022,m 1023,61024, * 1025,
 1026 and + 1027).
(TIF)
Table S1 Replication of DENV serotypes in vertebrate
and invertebrate cell lines.
(DOCX)
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Table S2 Detection of DENV in autopsy tissues of
human.
(DOCX)
Table S3 Phenotypic diversity within population of
DENV-1. The numerical fitness distribution within each
classification (more, average, less fit).
(DOCX)
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